Beinaglutide clinical trials
Also written GLP-1 (7-36) amide.
How each study uses beinaglutide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the beinaglutide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 9
Mannkind Corporation (2) · Xijing Hospital (1) · Papworth Hospital NHS Foundation Trust (1) · AstraZeneca (1) · Jeppe Skov (1) · University of Aarhus (1) · Beijing Hospital (1) · Johns Hopkins University (1)
Often tested with
Tested in the same studies.
Glucagon-like peptide 1 (7-36)amide (2) · Insulin Glargine (1) · Glyburide (1) · Metformin (1)
Related medicines
As reviewed, each with the page that says it.
- One of GLP-1 receptor agonists source
Studies
Open first, then newest update. How each study uses beinaglutide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM PatientsRecruitingNot applicableBeijing HospitalNCT03987308Written as BeinaglutideHow we know
- The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.Status unknownPhase 4Second Xiangya Hospital of Central South UniversityNCT05005741Written as BeinaglutideHow we know
- Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes MellitusCompletedNot applicableXijing HospitalNCT03829891Written as BeinaglutideHow we know
- Effects of Benaglutide on Weight and Gut Microbiota in Obese PatientsStatus unknownPhase 3Xiangya Hospital of Central South UniversityNCT03986008Written as BenaglutideHow we know
- Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight ControlStatus unknownPhase 4The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT03593668Written as BenaglutideHow we know
- Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) SurgeryTerminatedPhase 2Johns Hopkins UniversityNCT00966654Written as GLP-1 (7-36) amideHow we know
- Cardioprotective Effects of GLP-1 and Their MechanismsCompletedPhase 1Papworth Hospital NHS Foundation TrustNCT02128022Written as GLP-1 (7-36) amideHow we know
- PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart FailureCompletedPhase 2AstraZenecaNCT00099580Written as AC2592How we know
- A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes MellitusCompletedPhase 1Mannkind CorporationNCT00642538Written as MKC253 Inhalation PowderHow we know
- A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult MalesCompletedPhase 1Mannkind CorporationNCT00475371Written as MKC253 Inhalation PowderHow we know
- GLP-1: Acute Effects on Kidney Function in Healthy MenCompletedNot applicableJeppe SkovNCT01333163Written as Human GLP-1 (7-36) amideHow we know
- GLP-1 Infusion and Long-Time FastingCompletedNot applicableUniversity of AarhusNCT00285896Written as Glucagon-like-peptide-1 (7-36) amideHow we know
Codes
What other systems call beinaglutide · ClinicalTrials.gg INT003472
- UNII (FDA) 38I1O6L31DBEINAGLUTIDEOne source FDA
- NCI Thesaurus C166656BeinaglutideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 38I1O6L31D | BEINAGLUTIDE | One source FDA |
| NCI Thesaurus | C166656 | Beinaglutide | One source FDA |
Also registered as glucagon-like peptide-i(7-36) amide (UNII 0JS9125PIZ).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.